Transcriptional analysis of glioma patients revealed that high CD47 mRNA expression levels were associated with decreased progression-free and overall survival, suggesting that CD47 expression levels may serve as a clinically relevant prognostic factor (103). Here, CD47 is linked to central nervous system cancer.